Referencias bibliográficas

  1. Schildkraut JJ. The catecholamine hypothesis of affective disorders: A review of supporting eviden­ce. Am J Psychiatry. 1965; 122: 509-22.
  2. López-Muñoz F, Álamo C. Monoaminergic neu­rotransmission: the history of the discovery of anti­depressants from 1950s until today. Curr Pharm Des. 2009; 15: 1563-86.
  3. Álamo C, Zaragozá C, López-Muñoz F. Algo más que monoaminas en el tratamiento de la de­presión: Mecanismos neurobiológicos emergen­tes de los antidepresivos del siglo XXI. Revista de Investigación y Educación en Ciencias de la Salud (RIECS). 2020; 5 (2): 49-80.
  4. Zhao J., Goldberg J., Bremmer J.D. Vaccarino V. Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study”, Psycochom Med2013; 75: 523-529.
  5. Ulloa-Moreno S, Suárez-López A, Porras-Enriquez M. La función epigenética en la salud mental y las enfermedades neurodegenerativas. Revista Cubana de Investigaciones Biomédicas[Internet]. 2023 [citado 10 Jun 2024]; 42 (2).
  6. Amenyah SD, Hughes CF, Ward M, Rosborough S, Deane J, Thursby SJ, Walsh CP, Kok DE, Strain JJ, McNulty H, Lees-Murdock DJ. Influence of nutrients involved in one-carbon metabolism on DNA methylation in adults-a systematic review and meta-analysis. Nutr Rev. 2020 Aug 1;78(8):647-666.
  7. Li YF. A hypothesis of monoamine (5-HT) – Glu­tamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery. Pharmacol Ther. 2020; 208: 107494.
  8. Álamo C, García-Garcia P, Lopez-Muñoz F, Zara­gozá C. Tianeptine, an atypical pharmacological approach to depression. Rev Psiquiatr Salud Ment. 2019; 12 (3): 170-186.
  9. Popoli M., Yan Z., Mcewen B.S., Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission”, Nat Neurosci. 2012; 13: 22-37.
  10. McEwen B.S., Bowles N.P., Gray J.D. et al. Mechanisms of stress in the brain. Nat Neurosci. 2015; 18: 1353-1363.
  11. Dobrek L, Głowacka K. Depression and Its Phytopharmacotherapy-A Narrative Review. Int J Mol Sci. 2023 Mar 1;24(5):4772.
  12. Sharma A, Gerbarg P, Bottiglieri T, Massoumi L, Carpenter LL, Lavretsky H, Muskin PR, Brown RP, Mischoulon D; as Work Group of the American Psychiatric Association Council on Research. S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research. J Clin Psychiatry. 2017 Jun;78(6):e656-e667.
  13. Cuomo A, Beccarini Crescenzi B, Bolognesi S, Goracci A, Koukouna D, Rossi R, Fagiolini A. S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review. Ann Gen Psychiatry. 2020 Sep 5;19:50.
  14. Peng T-R, Cheng H-Y, Wu T-W. “S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis.” Gen Hosp Psychiatry. 2024 Jan-Feb:86:118-126.
  15. Limveeraprajak et al. Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta-analysis. Progress in Neuropsychopharmacology & Biological Psychiatry 132 (2024) 110985.
  16. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010 Jun;17(7):481-93.
  17. Risco E. Farmacología y clínica de la raíz de rodiola frente al estrés. Revista de Fitoterapia 2011; 11 (2): 101-117.
  18. Fanaras K, Reinhard H. “The effects of Rhodiola Rosea supplementation on depression, anxiety and mood – A Systematic Review” Global Psychiatry, vol.3, no.1, 2020, pp.72-82.
  19. Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine. 2015 Mar 15;22(3):394-9.
  20. Gao L, Wu C, Liao Y, Wang J. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial. J Affect Disord. 2020 Mar 15; 265:99-103.
  21. Hausenblas HA, Saha D, Dubyak PJ, Anton SD. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med. 2013; 11:377-383.
  22. Lopresti AL, Drummond PD. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol. 2014; 29: 517-527.
  23. Noorbala A A, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi A. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Journal of ethnopharmacology 2005; 97: 281-284.
  24. Kashani L, Eslatmanesh S, Saedi N, Niroomand N, Ebrahimi M, Hosseinian M, et al. Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial. Pharmacopsychiatry. 2017; 50: 64-68.
  25. Mazidi M, Shemshian M, Mousavi SH, Norouzy A, Kermani T, Moghiman T, et al. A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression. J Complement Integr Med. 2016; 13:195-199.
  26. Borges-Vieira JG, Cardoso CKS. Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials. Nutr Neurosci. 2023 Mar;26(3):187-207.
  27. Young LM, Pipingas A, White DJ, Gauci S, Scholey A. A Systematic Review and Meta-Analysis of B Vitamin Supplementation on Depressive Symptoms, Anxiety, and Stress: Effects on Healthy and ‘At-Risk’ Individuals. 2019 Sep 16;11(9):2232.
  28. Bekdash RA. Epigenetics, Nutrition, and the Brain: Improving Mental Health through Diet. International Journal of Molecular Sciences. 2024; 25(7):4036.
  29. Laird EJ, O’Halloran AM, Molloy AM, et al. Low vitamin B12 but not folate is associated with incident depressive symptoms in community-dwelling older adults: a 4-year longitudinal study. British Journal of Nutrition. 2023;130(2):268-275. doi:10.1017/S0007114521004748.
  30. Sangle P, Sandhu O, Aftab Z, Anthony AT, Khan S. Vitamin B12 Supplementation: Preventing Onset and Improving Prognosis of Depression. Cureus. 2020 Oct 26;12(10):e11169.